An Approach to the Identification of Potent Inhibitors of Influenza Virus Fusion Using Parallel Synthesis Methodology.

MS Deshpande,JM Wei,GX Luo,C Cianci,S Danetz,A Torri,L Tiley,M Krystal,KL Yu,S Huang,Q Gao,NA Meanwell
DOI: https://doi.org/10.1016/s0960-894x(01)00459-0
IF: 2.94
2001-01-01
Bioorganic & Medicinal Chemistry Letters
Abstract:Structure-activity studies associated with the salicylic acid-derived inhibitor of influenza fusion, BMY-27709, were examined using a parallel synthesis approach. This SAR survey led to the discovery of potent influenza inhibitory activity in a series of aromatic amides and thioamides derived from 1,3,3-trimethyl-5-hydroxycyclohexylmethylamine. Select compounds were characterized as inhibitors of the H1 subtype of influenza A viruses that act by preventing the pH-induced fusion process, thereby blocking viral entry into host cells. In a plaque-reduction assay, the most potent inhibitors displayed EC(50) values of 0.02-0.14 microg/mL.
What problem does this paper attempt to address?